← Leaderboards
Joji Fujisaki
Beth Israel Deaconess Medical Center
$10,346,925
Attributed
$12,049,997
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.2M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,049,997 · 4
By mechanism
R01$12,049,997 · 4
Top collaborators
- Iannis Elias Adamopoulos1 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Cornelis P Terhorst$22,963,281
- Keisuke Ito$9,818,052
- Daniel G Tenen$44,879,800
- Iannis Elias Adamopoulos$7,190,922
Others in their field
Top investigators on “Insight”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- James Dennis Neaton · Northwestern University$283,212,546
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$278,513,775
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
Research focus
InsightCellsBone MarrowHematopoietic Stem CellsTransplantationGenerationsTestisHematopoietic Stem Cell NicheTissuesExhibitsMolecularNovel Therapeutic InterventionImproved OutcomeRegulatory T-LymphocyteImmuneStem CellsPlacentaSiteStressFoxp3 GeneMolecular ProfilingSelf-RenewalIn VivoLocation
Grant awards (20)
The Impact of the Bone Marrow Niche's Immune Privilege on Psoriatic Arthritis$3,406,145
R01 · FY2025 · AI · contact PI
Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells$774,122
R01 · FY2025 · HL · contact PI
Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells$758,639
R01 · FY2024 · HL · contact PI
Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells$774,122
R01 · FY2023 · HL · contact PI
Identification of unique nitric oxide-expressing hematopoietic stem cells and their special vascular niche$459,692
R01 · FY2023 · DK · contact PI
Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells$774,122
R01 · FY2022 · HL · contact PI
Roles and therapeutic potential of CD150high niche-associated regulatory T cells in bone marrow injury and engraftment$493,287
R01 · FY2022 · HL · contact PI
Identification of unique nitric oxide-expressing hematopoietic stem cells and their special vascular niche$432,962
R01 · FY2022 · DK · contact PI
Roles and therapeutic potential of CD150high niche-associated regulatory T cells in bone marrow injury and engraftment$493,287
R01 · FY2021 · HL · contact PI
Identification of unique nitric oxide-expressing hematopoietic stem cells and their special vascular niche$344,792
R01 · FY2021 · DK · contact PI
Identification of unique nitric oxide-expressing hematopoietic stem cells and their special vascular niche$425,543
R01 · FY2020 · DK · contact PI
Immune privilege of the hematopoieitic stem cell niche$289,173
R01 · FY2020 · HL · contact PI
Roles and therapeutic potential of CD150high niche-associated regulatory T cells in bone marrow injury and engraftment$285,128
R01 · FY2020 · HL · contact PI
Roles and therapeutic potential of CD150high niche-associated regulatory T cells in bone marrow injury and engraftment$171,514
R01 · FY2020 · HL · contact PI
Immune privilege of the hematopoieitic stem cell niche$110,827
R01 · FY2020 · HL · contact PI
Roles and therapeutic potential of CD150high niche-associated regulatory T cells in bone marrow injury and engraftment$456,642
R01 · FY2019 · HL · contact PI
Immune privilege of the hematopoieitic stem cell niche$400,000
R01 · FY2019 · HL · contact PI
Immune privilege of the hematopoieitic stem cell niche$400,000
R01 · FY2018 · HL · contact PI
Immune privilege of the hematopoieitic stem cell niche$400,000
R01 · FY2017 · HL · contact PI
Immune privilege of the hematopoieitic stem cell niche$400,000
R01 · FY2016 · HL · contact PI